Established in 1994, this innovative R&D and manufacturing company focuses on the pharmaceutical and health sectors. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards, operating sophisticated drug production facilities that meet cGMP specifications from regulatory bodies such as NMPA, FDA, and EMA. The company's diverse portfolio includes biologics, small molecules, synthetic biologics, and special traditional Chinese medicines (TCMs), with over 300 product approvals across various categories. Its products are distributed in more than 40 countries and regions, including Singapore, South Korea, Italy, and China.

Founded in 2006, the Manufacturer is recognized as a CTD dossier owner and manufacturer specializing in biopharmaceuticals and healthcare. This GMP manufacturer operates advanced R&D centers and cGMP manufacturing facilities. As a CTD dossier owner and manufacturer, it offers a wide range of pharmaceutical and biotechnological products, serving major markets globally including the US, EU, and China. With rigorous GMP approvals, this CTD dossier owner and manufacturer continues to innovate and expand in the healthcare sector.

Established in 1986, this manufacturer employs approximately 1,451 individuals and specializes in heparin-related products, including standard heparin and low molecular weight heparin. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple countries, ensuring compliance with international quality standards. The manufacturer operates advanced production lines for both active pharmaceutical ingredients and finished dosage forms, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in over 60 countries worldwide